PFC
CDMO

Phocas Financial Corp’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Phocas Financial Corp’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-183,432
Closed -$2.27M – 167
2024
Q4 		$2.27M Sell
183,432
-1,688
-0.9% -$19.3K 0.3% 109
2024
Q3 		$2.11K Buy
+185,120
New +$1.86M 0.01% 132
2023
Q4 		– Sell
-244,903
Closed -$2.31M – 196
2023
Q3 		$2.31M Buy
244,903
+70,671
+41% +$851K 0.34% 108
2023
Q2 		$2.43M Sell
174,232
-1,124
-0.6% -$19.2K 0.33% 115
2023
Q1 		$3.29M Buy
175,356
+1,711
+1% +$28.1K 0.47% 87
2022
Q4 		$2.39M Sell
173,645
-180
-0.1% -$2.76K 0.34% 107
2022
Q3 		$3.32M Buy
173,825
+5,438
+3% +$99.1K 0.51% 87
2022
Q2 		$2.57M Sell
168,387
-1,890
-1% -$28K 0.39% 107
2022
Q1 		$3.47M Buy
170,277
+46,615
+38% +$949K 0.43% 93
2021
Q4 		$3.61M Sell
123,662
-13,121
-10% -$375K 0.46% 90
2021
Q3 		$2.95M Buy
+136,783
New +$3.3M 0.37% 105

Other funds holding CDMO

TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Phocas Financial Corp's CDMO Position: Q1 2025 in Review

Phocas Financial Corp sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 183,432 shares — an estimated $2.27M sold.

Phocas Financial Corp first reported a position in CDMO in Q3 2021 and held it in 11 quarters. The position peaked at $3.61M in Q4 2021. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • Phocas Financial Corp reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Phocas Financial Corp sold 183,432 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $2.27M.
  • Phocas Financial Corp first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2021 and held it in 11 quarters.
  • Phocas Financial Corp's Avid Bioservices, Inc. Common Stock position peaked at $3.61M in Q4 2021.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on Phocas Financial Corp's 13F filing for Q1 2025, filed 9 May 2025.